New concepts in white adipose tissue physiology

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 3, 2014, Pages 192-205

  Proenca A R G ^c   Sertie R A L ^a   Oliveira, A C ^b   Campana A B ^a   Caminhotto, R O ^a   Chimin, P ^a   Lima, F B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Adipogenesis; Adipose tissue; Endocrine; Lipogenesis; Lipolysis

Indexed keywords

ACETYL COENZYME A; ACYLGLYCEROL LIPASE; ADIPOCYTOKINE; ADIPONECTIN; ADRENALIN; APELIN; CCAAT ENHANCER BINDING PROTEIN; CHYLOMICRON; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FAT DROPLET; FATTY ACID; FATTY ACID BINDING PROTEIN 4; FATTY ACID SYNTHASE; GLYCEROL; GLYCEROPHOSPHATE; INSULIN; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NORADRENALIN; OMENTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASPIN; CYTOKINE;

ADIPOGENESIS; APOPTOSIS; DIABETES MELLITUS; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; IMMUNOMODULATION; INSULIN SENSITIVITY; LIPOGENESIS; LIPOLYSIS; LIPOTOXICITY; NONHUMAN; OBESITY; PHOSPHORYLATION; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; WHITE ADIPOSE TISSUE; ADIPOCYTE; ANIMAL; METABOLISM; MOUSE; PATHOPHYSIOLOGY; RAT; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOGENESIS; ADIPOKINES; ADIPOSE TISSUE, WHITE; ANIMALS; CYTOKINES; HUMANS; LEPTIN; LIPOLYSIS; MICE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; RATS; RESISTIN; SIGNAL TRANSDUCTION;

EID: 84898925547     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20132911     Document Type: Review

References (85)

1. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. [The adipose tissue as a regulatory center of the metabolism]. Arq Bras Endocrinol Metabol 2006; 50: 216-229. doi: 10.1590/S0004-27302006000200008.
2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432. doi: 10.1038/372425a0.
3. Ahima RS. Adipose tissue as an endocrine organ. Obesity 2006; 14 (Suppl 5): 242S-249S. doi: 10.1038/oby.2006.317.
4. Diraison F, Dusserre E, Vidal H, Sothier M, Beylot M. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2002; 282: E46-E51.
5. Swierczynski J, Goyke E, Wach L, Pankiewicz A, Kochan Z, Adamonis W, et al. Comparative study of the lipogenic potential of human and rat adipose tissue. Metabolism 2000; 49: 594-599. doi: 10.1016/S0026-0495(00)80033-5.
6. Girard J, Perdereau D, Foufelle F, Prip-Buus C, Ferre P. Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J 1994; 8: 36-42.
7. Park J, Rho HK, Kim KH, Choe SS, Lee YS, Kim JB. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol Cell Biol 2005; 25: 5146-5157. doi: 10.1128/ MCB.25.12.5146-5157.2005.
8. Coleman RA, Lee DP. Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res 2004; 43: 134-176. doi: 10.1016/S0163-7827(03)00051-1.
9. Nye CK, Hanson RW, Kalhan SC. Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat. J Biol Chem 2008; 283: 27565-27574. doi: 10.1074/jbc.M804393200.
10. Olswang Y, Cohen H, Papo O, Cassuto H, Croniger CM, Hakimi P, et al. A mutation in the peroxisome proliferatoractivated receptor gamma-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc Natl Acad Sci U S A 2002; 99: 625-630. doi: 10.1073/ pnas.022616299.
11. Agarwal AK, Garg A. Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol Metab 2003; 14: 214-221. doi: 10.1016/S1043- 2760(03)00078-X.
12. Wong RH, Sul HS. Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective. Curr Opin Pharmacol 2010; 10: 684-691. doi: 10.1016/j.coph.2010.08.004.
13. Haugen F, Drevon CA. The interplay between nutrients and the adipose tissue. Proc Nutr Soc 2007; 66: 171-182. doi: 10.1017/S0029665107005423.
14. Borland CA, Barber MC, Travers MT, Vernon RG. Inhibition of adipose tissue lipogenesis by growth hormone: role of polyamines. Biochem Soc Trans 1993; 21: 400S.
15. Rosenfeld RG, Hwa V. The growth hormone cascade and its role in mammalian growth. Horm Res 2009; 71 (Suppl 2): 36-40. doi: 10.1159/000192434.
16. Oswal A, Yeo G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity 2010; 18: 221-229. doi: 10.1038/oby.2009.228.
17. Nogalska A, Sucajtys-Szulc E, Swierczynski J. Leptin decreases lipogenic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats. Metabolism 2005; 54: 1041-1047. doi: 10.1016/j.metabol.2005.03.007.
18. Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J. Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 2008; 19: 130-137. doi: 10.1016/j.tem.2007.11.006.
19. Gravholt CH, Schmitz O, Simonsen L, Bulow J, Christiansen JS, Moller N. Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. Am J Physiol 1999; 277: E848-E854.
20. Gasic S, Tian B, Green A. Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations. J Biol Chem 1999; 274: 6770-6775. doi: 10.1074/jbc.274.10.6770.
21. Kiwaki K, Levine JA. Differential effects of adrenocorticotropic hormone on human and mouse adipose tissue. J Comp Physiol B 2003; 173: 675-678. doi: 10.1007/s00360- 003-0377-1.
22. Campbell JE, Peckett AJ, D'souza AM, Hawke TJ, Riddell MC. Adipogenic and lipolytic effects of chronic glucocorticoid exposure. Am J Physiol Cell Physiol 2011; 300: C198- C209. doi: 10.1152/ajpcell.00045.2010.
23. Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 2006; 53: 482-491. doi: 10.1016/j.phrs.2006.03.009.
24. de Glisezinski I, Larrouy D, Bajzova M, Koppo K, Polak J, Berlan M, et al. Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue. J Physiol 2009; 587: 3393-3404. doi: 10.1113/jphysiol.2009.168906.
25. Greenberg AS, Coleman RA, Kraemer FB, McManaman JL, Obin MS, Puri V, et al. The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest 2011; 121: 2102-2110. doi: 10.1172/JCI46069.
26. Unger RH, Zhou YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001; 50 (Suppl 1): S118-S121. doi: 10.2337/diabetes.50.2007.S118.
27. Boland MP, O'Neill LA. Ceramide activates NFkappaB by inducing the processing of p105. J Biol Chem 1998; 273: 15494-15500. doi: 10.1074/jbc.273.25.15494.
28. Lin KT, Xue JY, Nomen M, Spur B, Wong PY. Peroxynitriteinduced apoptosis in HL-60 cells. J Biol Chem 1995; 270: 16487-16490. doi: 10.1074/jbc.270.28.16487.
29. Lampidonis AD, Rogdakis E, Voutsinas GE, Stravopodis DJ. The resurgence of Hormone-Sensitive Lipase (HSL) in mammalian lipolysis. Gene 2011; 477: 1-11. doi: 10.1016/ j.gene.2011.01.007.
30. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011; 50: 14-27. doi: 10.1016/j.plipres.2010.10.004.
31. Xu L, Zhou L, Li P. CIDE proteins and lipid metabolism. Arterioscler Thromb Vasc Biol 2012; 32: 1094-1098. doi: 10.1161/ATVBAHA.111.241489.
32. Sztalryd C, Xu G, Dorward H, Tansey JT, Contreras JA, Kimmel AR, et al. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol 2003; 161: 1093-1103. doi: 10.1083/jcb.200210169.
33. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004; 306: 1383-1386. doi: 10.1126/science.1100 747.
34. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-737. doi: 10.1126/science. 1123965.
35. Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, Mizunoya W, et al. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest 2008; 118: 2808-2821.
36. Yang X, Heckmann BL, Zhang X, Smas CM, Liu J. Distinct mechanisms regulate ATGL-mediated adipocyte lipolysis by lipid droplet coat proteins. Mol Endocrinol 2013; 27: 116-126. doi: 10.1210/me.2012-1178.
37. Yang X, Lu X, Lombes M, Rha GB, Chi YI, Guerin TM, et al. The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab 2010; 11: 194-205. doi: 10.1016/j.cmet.2010.02.003.
38. Brasaemle DL. Perilipin 5: putting the brakes on lipolysis. J Lipid Res 2013; 54: 876-877. doi: 10.1194/jlr.E036962.
39. Wang H, Bell M, Sreenivasan U, Hu H, Liu J, Dalen K, et al. Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein. J Biol Chem 2011; 286: 15707-15715. doi: 10.1074/jbc.M110.207779.
40. Tang QQ, Lane MD. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev 1999; 13: 2231-2241. doi: 10.1101/gad.13.17.2231.
41. Salma N, Xiao H, Imbalzano AN. Temporal recruitment of CCAAT/enhancer-binding proteins to early and late adipogenic promoters in vivo. J Mol Endocrinol 2006; 36: 139-151. doi: 10.1677/jme.1.01918.
42. Tang QQ, Otto TC, Lane MD. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci U S A 2003; 100: 850-855. doi: 10.1073/pnas.0337434100.
43. Siersbaek R, Nielsen R, John S, Sung MH, Baek S, Loft A, et al. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J 2011; 30: 1459-1472. doi: 10.1038/emboj.2011.65.
44. Meruvu S, Hugendubler L, Mueller E. Regulation of adipocyte differentiation by the zinc finger protein ZNF638. J Biol Chem 2011; 286: 26516-26523. doi: 10.1074/jbc. M110.212506.
45. Xiao J, Sun B, Cai GP. Transient expression of interferoninducible p204 in the early stage is required for adipogenesis in 3T3-L1 cells. Endocrinology 2010; 151: 3141-3153. doi: 10.1210/en.2009-1381.
46. Musri MM, Carmona MC, Hanzu FA, Kaliman P, Gomis R, Parrizas M. Histone demethylase LSD1 regulates adipogenesis. J Biol Chem 2010; 285: 30034-30041. doi: 10.1074/ jbc.M110.151209.
47. Okamura M, Inagaki T, Tanaka T, Sakai J. Role of histone methylation and demethylation in adipogenesis and obesity. Organogenesis 2010; 6: 24-32. doi: 10.4161/org.6.1.11121.
48. Donzelli E, Lucchini C, Ballarini E, Scuteri A, Carini F, Tredici G, et al. ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation. J Mol Cell Biol 2011; 3: 123-131. doi: 10.1093/jmcb/mjq050.
49. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999; 38: 202-206. doi: 10.2169/internalmedicine. 38.202.
50. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012; 8: 457-465. doi: 10.1038/nrendo.2012.49.
51. Fried SK, Ricci MR, Russell CD, Laferrere B. Regulation of leptin production in humans. J Nutr 2000; 130: 3127S-3131S.
52. Tartaglia LA. The leptin receptor. J Biol Chem 1997; 272: 6093-6096.
53. Gao S, Kinzig KP, Aja S, Scott KA, Keung W, Kelly S, et al. Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. Proc Natl Acad Sci U S A 2007; 104: 17358-17363. doi: 10.1073/pnas.0708385104.
54. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002; 415: 339-343. doi: 10.1038/415339a.
55. Schaffler A, Scholmerich J, Salzberger B. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 2007; 28: 393-399. doi: 10.1016/ j.it.2007.07.003.
56. Paz-Filho G, Wong ML, Licinio J. Ten years of leptin replacement therapy. Obes Rev 2011; 12: e315-e323. doi: 10.1111/j.1467-789X.2010.00840.x.
57. Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF. Adiponectin action from head to toe. Endocrine 2010; 37: 11-32. doi: 10.1007/s12020-009-9278- 8.
58. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278: 40352-40363. doi: 10.1074/jbc.M300365200.
59. Lee MH, Klein RL, El-Shewy HM, Luttrell DK, Luttrell LM. The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry 2008; 47: 11682-11692. doi: 10.1021/bi801451f.
60. Kim JH, Bachmann RA, Chen J. Interleukin-6 and insulin resistance. Vitam Horm 2009; 80: 613-633. doi: 10.1016/ S0083-6729(08)00621-3.
61. Hoene M, Weigert C. The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev 2008; 9: 20-29.
62. Li G, Klein RL, Matheny M, King MA, Meyer EM, Scarpace PJ. Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats. Neuroscience 2002; 115: 879-889. doi: 10.1016/S0306-4522(02)00447-5.
63. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316: 129-139. doi: 10.1016/j.mce.2009.08.018.
64. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005; 11: 183-190. doi: 10.1038/nm1166.
65. Schwartz DR, Lazar MA. Human resistin: found in translation from mouse to man. Trends Endocrinol Metab 2011; 22: 259-265.
66. Yvan-Charvet L, Quignard-Boulange A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int 2011; 79: 162-168. doi: 10.1038/ki.2010.391.
67. Briones AM, Nguyen Dinh CA, Callera GE, Yogi A, Burger D, He Y, et al. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 2012; 59: 1069-1078. doi: 10.1161/ HYPERTENSIONAHA.111.190223.
68. Yiannikouris F, Gupte M, Putnam K, Thatcher S, Charnigo R, Rateri DL, et al. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 2012; 60: 1524-1530. doi: 10.1161/HYPERTE NSIONAHA.112.192690.
69. Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008; 17: 327-333. doi: 10.1517/13543784.17.3.327.
70. Shaker OG, Sadik NA. Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance. Mol Cell Biochem 2013; 373: 229-239. doi: 10.1007/s11010-012- 1494-5.
71. Kobat MA, Celik A, Balin M, Altas Y, Baydas A, Bulut M, et al. The investigation of serum vaspin level in atherosclerotic coronary artery disease. J Clin Med Res 2012; 4: 110-113.
72. Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010; 2010: 535-918. doi: 10.1155/2010/535918.
73. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-430. doi: 10.1126/science.1097243.
74. Romacho T, Sanchez-Ferrer CF, Peiro C. Visfatin/Nampt: an adipokine with cardiovascular impact. Mediators Inflamm 2013; 2013: 9464-9467. doi: 10.1155/2013/946427.
75. Moschen AR, Gerner RR, Tilg H. Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity- related disorders. Curr Pharm Des 2010; 16: 1913-1920. doi: 10.2174/138161210791208947.
76. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007; 56: 1655-1661. doi: 10.2337/db06-1506.
77. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. Omentin, a novel adipocytokine inhibits TNFinduced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011; 408: 339-343. doi: 10.1016/j.bbrc.2011.04.039.
78. Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 2010; 393: 668-672. doi: 10.1016/j.bbrc.2010.02.053.
79. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 2008; 118: 3343-3354.
80. Wang W, McKinnie SM, Patel VB, Haddad G, Wang Z, Zhabyeyev P, et al. Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues. J Am Heart Assoc 2013; 2: e000249.
81. Higuchi K, Masaki T, Gotoh K, Chiba S, Katsuragi I, Tanaka K, et al. Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 2007; 148: 2690-2697. doi: 10.1210/en.2006-1270.
82. Jensen MD, Ekberg K, Landau BR. Lipid metabolism during fasting. Am J Physiol Endocrinol Metab 2001; 281: E789-E793.
83. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-alpha-dependent myokine that drives brownfat- like development of white fat and thermogenesis. Nature 2012; 481: 463-468. doi: 10.1038/nature10777.
84. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008; 88: 1379-1406. doi: 10.1152/physrev.90100.2007.
85. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990; 8: 253-278. doi: 10.1146/annurev.iy.08.040190.001345.